Literature DB >> 23758074

Quercetin treatment against ischemia/reperfusion injury in rat corpus cavernosum tissue: a role on apoptosis and oxidative stress.

Ö Çevik1, S Çadırcı, T E Şener, I Tinay, C Akbal, H H Tavukçu, S Çetinel, D Kıran, G Şener.   

Abstract

Reactive oxygen metabolites play an important role in the ischemia/reperfusion (I/R)-induced tissue injury. This study was designed to investigate the possible protective effects of quercetin against I/R injury of the rat corpus cavernosum tissue. To induce I/R injury, abdominal aorta was clamped for 30 min and reperfused for 60 min. Quercetin (20 mg/kg) or vehicle was given before ischemia and just after reperfusion in the I/R group and in the sham-operated control group in which clamping was not performed. After decapitation, corpus cavernosum tissues were removed and either placed in organ baths or stored for evaluating biochemical parameters. Oxidative injury was examined by measuring lucigenin chemiluminescence (CL), nitric oxide (NO), malondialdehyde (MDA) and glutathione (GSH) levels, superoxide dismutase (SOD) and myeloperoxidase (MPO) activities and caspase-3 protein levels. In the I/R group, contractile responses to phenylephrine and relaxation responses to carbachol were impaired significantly compared with those in the control groups, while quercetin treatment in I/R group reversed both of the responses. On the other hand, increase in lucigenin CL, NO, MDA levels and MPO and caspase-3 activities and decrease in GSH levels and SOD activity in the cavernosal tissues of the I/R group were also significantly reversed by quercetin treatment. Furthermore, observed distorted morphology with ruptured endothelial cells and vacuolization in the cytoplasm of cavernosal tissues of I/R no longer persisted in the quercetin-treated I/R group. Thus, our results suggested that treatment with quercetin may have some benefits in controlling I/R-induced tissue injury through its anti-inflammatory, anti-apoptotic, and antioxidant effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23758074     DOI: 10.3109/10715762.2013.814912

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  7 in total

1.  Effect of chemotherapy exposure prior to pregnancy on fetal brain tissue and the potential protective role of quercetin.

Authors:  Z Doğan; S Kocahan; E Erdemli; E Köse; I Yılmaz; Z Ekincioğlu; N Ekinci; Y Turkoz
Journal:  Cytotechnology       Date:  2014-09-27       Impact factor: 2.058

2.  The effect of Momordica charantia intake on the estrogen receptors ESRα/ESRβ gene levels and apoptosis on uterine tissue in ovariectomy rats.

Authors:  Ozge Cevik; Hikmet Akpinar; Rabia Oba; Ozlem Tugce Cilingir; Zarife Nigar Ozdemir; Sule Cetinel; Tevfik Yoldemir
Journal:  Mol Biol Rep       Date:  2014-09-25       Impact factor: 2.316

Review 3.  Natural Compounds Modulating Mitochondrial Functions.

Authors:  Lara Gibellini; Elena Bianchini; Sara De Biasi; Milena Nasi; Andrea Cossarizza; Marcello Pinti
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-18       Impact factor: 2.629

4.  Comparison of quercetin and resveratrol in the prevention of injury due to testicular torsion/detorsion in rats.

Authors:  Kai-Kai Chi; Wen-Hui Zhang; Zhu Chen; Yong Cui; Wei He; Suo-Gang Wang; Chan Zhang; Jie Chen; Guang-Ce Wang
Journal:  Asian J Androl       Date:  2016 Nov-Dec       Impact factor: 3.285

Review 5.  Natural Drugs as a Treatment Strategy for Cardiovascular Disease through the Regulation of Oxidative Stress.

Authors:  Xing Chang; Tian Zhang; Wenjin Zhang; Zhenyu Zhao; Jiahui Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-27       Impact factor: 6.543

6.  Letter to the Editor: Effects of Omega-3 Fatty Acids on Erectile Dysfunction in a Rat Model of Atherosclerosis-induced Chronic Pelvic Ischemia.

Authors:  Emin Özbek
Journal:  J Korean Med Sci       Date:  2017-12       Impact factor: 2.153

7.  Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment.

Authors:  Margarida Ferreira-Silva; Catarina Faria-Silva; Manuela C Carvalheiro; Sandra Simões; H Susana Marinho; Paulo Marcelino; Maria Celeste Campos; Josbert M Metselaar; Eduarda Fernandes; Pedro V Baptista; Alexandra R Fernandes; Maria Luísa Corvo
Journal:  Pharmaceutics       Date:  2022-01-03       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.